Money & Markets

QQQ Futures Slide 1.26% Ahead of Nvidia Earnings and Anthropic Debut

QQQ futures fell 1.26% ahead of Nvidia's Tuesday earnings as the chipmaker logged its worst weekly streak since 2012. Anthropic's 825M-share IPO starts trading Nov 19.

By Grace Kim

3 min read

Research 16.11.2026
Research 16.11.2026AS_Photography / pixabay

What's News

  • QQQ fell $8.60, or 1.26%, pre-market on Nov 16, 2026, ahead of Nvidia's Tuesday Q3 report.
  • Nvidia posted its longest weekly losing streak since October 2012; the FT reported Jensen Huang may return as CEO.
  • Anthropic's IPO covers 825 million shares at $70–$78, with trading expected to start Thursday, Nov 19.
  • Morgan Stanley set an end-2027 S&P 500 target of 8,700 and 2027 EPS of $420.
  • Markets fully price a December Fed rate hike, with about 8% odds of a 50bp move (CME FedWatch).

Nasdaq-100 futures pointed sharply lower on November 16, 2026, with the Invesco QQQ Trust (QQQ) down $8.60, or 1.26%, in pre-market trading, while SPY slipped $4.45, or 0.59%. The slide comes as S&P 500 and Nasdaq futures fall ahead of Nvidia's earnings and Anthropic's market debut, according to the hi2morrow team's morning research note.

The macro calendar is crowded. Three Federal Reserve officials speak during the session:

  • 08:30 — NY Empire State Manufacturing Index
  • 09:05 — Fed's Williams speaks
  • 12:00 — Fed Chair Warsh speaks
  • 18:10 — Fed's Barkin speaks

Why is Nvidia dragging the whole semiconductor complex lower?

Nvidia (NVDA) extended losses after its longest weekly losing streak since October 2012, triggered by Jensen Huang's exit as CEO. The Financial Times reported Huang is now considering a return to the role. Treasury Secretary Bessent added pressure, saying Nvidia needs to "go outside the company" to find a new CEO. Nvidia reports Q3 results on Tuesday.

The nervousness spread across the chip and AI infrastructure complex before the print:

  • Semiconductors: TSM, AVGO, AMD, INTC, ARM, MRVL, AMAT, LRCX, KLAC, ASML
  • Memory and storage: SKHY, MU, SNDK, WDC, STX
  • Neoclouds and data-center names: CRWV, NBIS, IREN, APLD, CORZ, ORCL
  • Server makers: DELL, HPE, SMCI
  • Optical, networking and AI power: COHR, LITE, CRDO, ALAB, ANET, BE, VRT, GEV

Analysts told Reuters the Nvidia turmoil could overshadow Trump–Xi talks scheduled later this week.

Which stocks are actually rising?

Healthcare bucked the tech rout. JNJ, UNH, BMY, GSK and REGN all traded higher. Novo Nordisk (NVO) gained after additional CagriSema weight-loss trial analyses.

Earnings reactions also lifted names on both sides of the market:

  • Gap ups: HTHT, XPEV, BEKE, TSN
  • Gap downs: ARMK, BIDU

XPeng (XPEV) rose after Q3 results, even as its net loss widened amid a subdued Chinese auto market. TELUS (TU) soared after confirming receipt of an unsolicited proposal from Quebecor, adding that it continues its review of strategic alternatives. Baidu (BIDU) fell after Q3 adjusted profit missed, as an ad slump outweighed its AI cloud surge, per Reuters.

Where were the biotech shocks?

Summit Therapeutics (SMMT) plunged after the FDA declined to approve its China-developed lung cancer drug. Cybin (HELP) traded lower despite positive Phase 3 APPROACH results for HLP003 as an adjunctive treatment in major depressive disorder. Aclaris Therapeutics (ACRS) fell after top-line Phase 2 results for its anti-TSLP antibody bosakitug in atopic dermatitis.

What else moved?

Crypto-linked stocks slid as bitcoin dropped toward $64,600, dragging MSTR, COIN, HOOD, CRCL, BMNR, MARA and GLXY lower. Copper miners Freeport-McMoRan (FCX) and BHP declined as copper sank to a four-month low on the tech rout and China growth worries.

In rates, markets now fully price a Fed rate hike in December, with about 8% odds of a 50bp move, according to CME FedWatch. FOMC minutes land Wednesday. The 2-year Treasury yield slipped about 2bp after its largest weekly rise in more than two years, while the 10-year sits near 5.12%. The euro fell to its lowest in more than 18 months, and WTI crude traded near $87.9.

Two other items frame the week. Morgan Stanley raised global equities to "maximum overweight," set an end-2027 S&P 500 target of 8,700 and forecast 2027 EPS of $420. Anthropic's IPO prices 825 million shares at $70–$78, with trading expected to begin Thursday, November 19. A US senator also accused the Commerce Department of failing to stem the flow of AI chips to China, Reuters reported.

With Nvidia's numbers, the Fed minutes and Anthropic's debut all landing within four trading days, positioning risk sits at the center of this tape.

By Grace Kim

Source: tradingview.com

Share this article:

More from Grace Kim

Grace Kim

Show full bio

Market editor covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.

2,178 articles

Related articles

« Previous articleNext article »